Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report)’s stock price gapped up prior to trading on Monday . The stock had previously closed at $16.27, but opened at $16.60. Sionna Therapeutics shares last traded at $16.00, with a volume of 29,024 shares trading hands.
Wall Street Analyst Weigh In
Several analysts have issued reports on SION shares. Stifel Nicolaus started coverage on Sionna Therapeutics in a report on Tuesday, March 4th. They set a “buy” rating and a $32.00 price objective on the stock. Guggenheim started coverage on shares of Sionna Therapeutics in a report on Tuesday, March 4th. They set a “buy” rating and a $45.00 price target on the stock. Finally, TD Cowen began coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating on the stock.
View Our Latest Stock Report on Sionna Therapeutics
Sionna Therapeutics Trading Down 1.6 %
Sionna Therapeutics Company Profile
We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.
Featured Articles
- Five stocks we like better than Sionna Therapeutics
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Investing in Commodities: What Are They? How to Invest in Them
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
- How to Invest in the Best Canadian Stocks
- Energy and Basic Materials Sectors Will Dominate in 2025
Receive News & Ratings for Sionna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sionna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
